Korean J Fam Pract. 2018; 8(6): 808-819  https://doi.org/10.21215/kjfp.2018.8.6.808
The Association between Lifestyle Therapy and Dyslipidemia Control in Korean Adults: The Fourth to Sixth Korean National Health and Nutrition Examination Survey (2007-2015)
Su Hwan Cho1, Jong-Soo Han2,*, In Young Cho2, Oh Deok Kwon1, Sun Young Park1, Ho Jun Kim1
1Department of Family Medicine, Seoul National University Hospital, Seoul; 2Department of Family Medicine, Health Promotion Center, Seoul National University Bundang Hospital, Seongnam, Korea
Jong-Soo Han
Tel: +82-31-787-7807, Fax: +82-31-787-4834
E-mail: flindt@snubh.org
ORCID: http://orcid.org/0000-0001-9248-9998
Received: August 16, 2017; Revised: October 11, 2017; Accepted: October 12, 2017; Published online: December 20, 2018.
© The Korean Academy of Family Medicine. All rights reserved.

This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Background: Dyslipidemia is a major risk factor for cardiovascular disease, and its prevalence is steadily rising. In addition to medication, lifestyle therapy is also important for the control of dyslipidemia.
Methods: We utilized data from the Fourth to Sixth Korean National Health and Nutrition Examination Survey and included a total of 4,384 patients with dyslipidemia. Further, we employed logistic regression analysis using a weighted method to determine whether the control of dyslipidemia was associated with lifestyle therapy as is suggested in clinical dyslipidemia guidelines. Lifestyle therapy includes both behavioral factors (smoking, alcohol consumption and exercise level) and nutritional factors (adequate intake and regulation of fiber, carbohydrates, fats, saturated fats, sodium, and cholesterol).
Results: The control of dyslipidemia in men was associated with excessive alcohol consumption (OR 1.38, [95% CI 1.03?1.86]) and adequate physical activity (1.42, [1.02?1.98]). There were no significant differences with regards to the nutritional factor variables in men and any of the variables in women. In our subgroup analyses, control of dyslipidemia in the high-risk group taking medication was associated with a higher smoking rate (1.91, [1.10?3.30]) and an adequate sodium intake (1.76, [1.07?2.91]). In the low-risk group taking medication, the control of dyslipidemia was associated with a lower smoking rate (0.36, [0.14?0.93]) and adequate physical activity (4.20, [1.22?14.47]).
Conclusion: Adequate physical activity may be a key factor in the control of dyslipidemia. For the better control of dyslipidemia, the importance of lifestyle therapy should be emphasized.
Keywords: Dyslipidemia; Life Style; Behavior; Smoking; Alcohol Drinking; Exercise; Guideline; Diet
  1. WHO. Global status report on noncommunicable diseases 2014. Geneva:WHO; 2014.
  2. Statistics Korea. Annual report on the cause of death statistics 2015 [Internet]. Daejeon: Statistics Korea; 2016 [cited 2016 Sep 27].
  3. Farzadfar F, Finucane MM, Danaei G, Pelizzari PM, Cowan MJ, Paciorek CJ, et al. National, regional, and global trends in serum total cholesterol since 1980: systematic analysis of health examination surveys and epidemiological studies with 321 country-years and 3·0 million participants. Lancet 2011;377: 578-86.
  4. LaRosa JC, He J, Vupputuri S. Effect of statins on risk of coronary disease: a meta-analysis of randomized controlled trials. JAMA 1999; 282: 2340-6.
    Pubmed CrossRef
  5. Cholesterol Treatment Trialists’ (CTT) Collaboration, Baigent C, Blackwell L, Emberson J, Holland LE, Reith C, et al. Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials. Lancet 2010; 376: 1670-81.
  6. Committee for the Korean Guidelines for the Management of Dyslipidemia. 2015 Korean guidelines for the management of dyslipidemia: executive summary (english translation). Korean Circ J 2016; 46: 275-306.
    Pubmed KoreaMed CrossRef
  7. National Clinical Guideline Centre (UK). Lipid modification: cardiovascular risk assessment and the modification of blood lipids for the primary and secondary prevention of cardiovascular disease. London: National Institute for Health and Care Excellence (UK); 2014.
  8. Jacobson TA, Maki KC, Orringer CE, Jones PH, Kris-Etherton P, Sikand G, et al. National Lipid Association recommendations for patient-centered management of dyslipidemia: part 2. J Clin Lipidol 2015; 9(6 Suppl): S1-122. e1.
  9. Catapano AL, Graham I, De Backer G, Wiklund O, Chapman MJ, Drexel H, et al. 2016 ESC/EAS guidelines for the management of dyslipidaemias. Eur Heart J 2016; 37: 2999-3058.
    Pubmed CrossRef
  10. Villegas R, Kearney PM, Perry IJ. The cumulative effect of core lifestyle behaviours on the prevalence of hypertension and dyslipidemia. BMC Public Health 2008; 8: 210.
    Pubmed KoreaMed CrossRef
  11. Stampfer MJ, Hu FB, Manson JE, Rimm EB, Willett WC. Primary prevention of coronary heart disease in women through diet and lifestyle. N Engl J Med 2000; 343: 16-22.
    Pubmed CrossRef
  12. Ornish D, Scherwitz LW, Billings JH, Brown SE, Gould KL, Merritt TA, et al. Intensive lifestyle changes for reversal of coronary heart disease. JAMA 1998; 280: 2001-7.
    Pubmed CrossRef
  13. World Health Organization. Regional Office for the Western Pacific. The Asia-Pacific perspective: redefining obesity and its treatment. Sydney:Health Communications Australia; 2000.
  14. Lee S, Park HS, Kim SM, Kwon HS, Kim DY, Kim DJ, et al. Cut-off points of waist circumference for defining abdominal obesity in the Korean population. Korean J Obes 2006; 15: 1-9.
  15. Zhang FL, Xing YQ, Wu YH, Liu HY, Luo Y, Sun MS, et al. The prevalence, awareness, treatment, and control of dyslipidemia in northeast China: a population-based cross-sectional survey. Lipids Health Dis 2017; 16: 61.
    Pubmed KoreaMed CrossRef
  16. WHO. Global status report on alcohol and health 2011. Geneva: WHO;2011.
  17. Schnohr P, Lange P, Scharling H, Jensen JS. Long-term physical activity in leisure time and mortality from coronary heart disease, stroke, respiratory diseases, and cancer. The Copenhagen City Heart Study. Eur J Cardiovasc Prev Rehabil 2006; 13: 173-9.
    Pubmed CrossRef
  18. Leitzmann MF, Park Y, Blair A, Ballard-Barbash R, Mouw T, Hollenbeck AR, et al. Physical activity recommendations and decreased risk of mortality. Arch Intern Med 2007; 167: 2453-60.
    Pubmed CrossRef
  19. Pedersen BK, Saltin B. Evidence for prescribing exercise as therapy in chronic disease. Scand J Med Sci Sports 2006; 16 Suppl 1: 3-63.
    Pubmed CrossRef
  20. Aadahl M, von Huth Smith L, Pisinger C, Toft UN, Glümer C, Borch-Johnsen K, et al. Five-year change in physical activity is associated with changes in cardiovascular disease risk factors: the Inter99 study. Prev Med 2009; 48:326-31.
    Pubmed CrossRef
  21. American College of Sports Medicine. ACSM’s guidelines for exercise testing and prescription. 9th ed. Philadelphia: Lippincott Williams and Wilkins;2014.

This Article

Author ORCID Information

Social Network Service